Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Praechompoo Pongtornpipat"'
Autor:
William J Dower, Angie Inkyung Park, Alice V Bakker, Steven E Cwirla, Praechompoo Pongtornpipat, Blake M Williams, Prarthana Joshi, Bryan A Baxter, Michael C Needels, Ronald W Barrett
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0286834 (2023)
Interleukin (IL)-7 is broadly active on T-cell populations, and modified versions have been clinically evaluated for a variety of therapeutic applications, including cancer, lymphopenia, and infectious diseases; and found to be relatively well-tolera
Externí odkaz:
https://doaj.org/article/3bd59ccdb97e4f0fb8a0e9145823542e
Autor:
William Dower, Alice Bakker, Steven Cwirla, Prarthana Joshi, Praechompoo Pongtornpipat, Blake Williams, Michael Needels, Ronald Barrett
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/1b97f15b8df443b49bcae65a6577cdad
Autor:
William Dower, Alice Bakker, Steven Cwirla, Prarthana Joshi, Praechompoo Pongtornpipat, Blake Williams, Sandra Wang, Michael Needels, Ronald Barrett
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/39219be9b5974bbeaf2f38cc3bb3e06a
Autor:
William Dower, Alice Bakker, Steven Cwirla, Prarthana Joshi, Praechompoo Pongtornpipat, Blake Williams, Sandra Wang, Michael Needels, Ronald Barrett
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/57d3a382552e40e1ac2426429045bc03
Autor:
William Dower, Alice Bakker, Steven Cwirla, Prarthana Joshi, Praechompoo Pongtornpipat, Blake Williams, Sandra Wang, Michael Needels, Ronald Barrett
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/accd91a16d9c485a85884167210aa877
Autor:
William J. Dower, Angie Inkyung Park, Alice V. Bakker, Steven E. Cwirla, Praechompoo Pongtornpipat, Blake M. Williams, Prarthana Joshi, Bryan A. Baxter, Michael C. Needels, Ronald W. Barrett
Interleukin (IL)-7 is broadly active on T-cell populations, and modified versions have been clinically evaluated for a variety of therapeutic applications, including cancer, lymphopenia and infectious diseases; and found to be relatively well-tolerat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7ff65917a24a1a813fbc673b68412542
https://doi.org/10.1101/2023.05.24.542196
https://doi.org/10.1101/2023.05.24.542196
Autor:
Jonathan H. Schatz, Eli Chapman, Abimael D. Rodríguez, Graham Packham, Cyril H. Benes, Francisco Vega, Patricia Greninger, Gillian Paine-Murrieta, Andrew J. Ambrose, Christopher J. Zerio, Praechompoo Pongtornpipat, Amit D. Amin, Lingxiao Li, Luis A. Amador, Carlos Jiménez-Romero, Elizabeth Lemm, Sarah Wilmore, Alison M. Yeomans, Joseph Tillotson, Tara L. Peters
Figure S1. Elatol was submitted to a 96-member kinome screen to evaluate specificity. Figure S2. A) Michaelis-Menten curves of eIF4A1 wild type (blue), K82R (red), and K238E (green). Michaelis- Menten constants for eIF4A1 wild type and mutants in tab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43b0c08aa1ad75e37b8b895a22244a71
https://doi.org/10.1158/1078-0432.22469778.v1
https://doi.org/10.1158/1078-0432.22469778.v1
Autor:
Jonathan H. Schatz, Eli Chapman, Abimael D. Rodríguez, Graham Packham, Cyril H. Benes, Francisco Vega, Patricia Greninger, Gillian Paine-Murrieta, Andrew J. Ambrose, Christopher J. Zerio, Praechompoo Pongtornpipat, Amit D. Amin, Lingxiao Li, Luis A. Amador, Carlos Jiménez-Romero, Elizabeth Lemm, Sarah Wilmore, Alison M. Yeomans, Joseph Tillotson, Tara L. Peters
Purpose: The DEAD-box RNA helicase eIF4A1 carries out the key enzymatic step of cap-dependent translation initiation and is a well-established target for cancer therapy, but no drug against it has entered evaluation in patients. We identified and cha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e0a4100a7388fdcb4d088138f676666
https://doi.org/10.1158/1078-0432.c.6527340
https://doi.org/10.1158/1078-0432.c.6527340
Autor:
Jonathan H. Schatz, Soham D. Puvvada, Yves A. Lussier, Lisa M. Rimsza, Jonathan Adkins, Lori Cuyugan, Tara L. Peters, Edgar O. Tapia, Matthew J. Groysman, Praechompoo Pongtornpipat, Winnie S. Liang, Soumya S. Rajan, Amit Dipak Amin
Supplementary Tables S1-S2. Relative IC50's of ALK+ and ALK- ALCL cell lines to the ALK tyrosine kinase inhibitors crizotinib and ceritinib (S1); ALK Kinase-Domain Sequencing Results (S2).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1f3399ead6ef9ebe83b0200a630176b
https://doi.org/10.1158/0008-5472.22405214.v1
https://doi.org/10.1158/0008-5472.22405214.v1
Autor:
Jonathan H. Schatz, Soham D. Puvvada, Yves A. Lussier, Lisa M. Rimsza, Jonathan Adkins, Lori Cuyugan, Tara L. Peters, Edgar O. Tapia, Matthew J. Groysman, Praechompoo Pongtornpipat, Winnie S. Liang, Soumya S. Rajan, Amit Dipak Amin
Supplementary Figures S1-S5. Timelines for acquired resistance and resensitization (S1); Assessment of copy number changes in additional subclones (S2); RS lines behave like original parent cells with return of ALK expression to baseline (S3); Resele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c09c6e35d3b74b7a4d3f9c5b3fc1981
https://doi.org/10.1158/0008-5472.22405220
https://doi.org/10.1158/0008-5472.22405220